Inflammation, immunity, and vaccine development for Helicobacter pylori.
about
Dysbiotic infection in the stomachTherapy of Helicobacter pylori: present medley and future prospectiveHelicobacter pylori in humans: Where are we now?A role for altered phagosome maturation in the long-term persistence of Helicobacter pylori infectionAt the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancerChinese Helicobacter pylori vaccine: Solution for an old challenge?Host Determinants of Expression of the Helicobacter pylori BabA Adhesin.Helicobacter pylori infection: new pathogenetic and clinical aspects.The gastric microbial community, Helicobacter pylori colonization, and disease.Survival in hostile territory: the microbiota of the stomach.The impact of Helicobacter pylori infection on the gastric microbiota of the rhesus macaque.Immunization with Heat Shock Protein A and γ-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice.The Detection of Helicobacter hepaticus Using Whispering-Gallery Mode Microcavity Optical Sensors.Helicobacter pylori Infection Is Associated with Higher CD4 T Cell Counts and Lower HIV-1 Viral Loads in ART-Naïve HIV-Positive Patients in Ghana.Management of Helicobacter pylori infectionsImmunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c micePangenome and immuno-proteomics analysis of Acinetobacter baumannii strains revealed the core peptide vaccine targets.Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells.Leptin, CD4(+) T(reg) and the prospects for vaccination against H. pylori infection.Intestinal commensal microbes as immune modulators.Complex T cell interactions contribute to Helicobacter pylori gastritis in miceLife in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori.Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine.Helicobacter pylori overcomes natural immunity in repeated infections.Biomarkers of Helicobacter pylori-associated gastric cancer.Why can't we make an effective vaccine against Helicobacter pylori?Strategies used by helicobacter pylori to establish persistent infectionAlterations in Th17 and the Respective Cytokine Levels in Helicobacter pylori-Induced Stomach Diseases.NF-κB activation and severity of gastritis in Helicobacter pylori-infected children and adults.A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-γ production and is associated with Helicobacter pylori-induced gastric disease.DoHelicobacter pyloritherapeutic vaccines need to be tailored to the age of the recipient?
P2860
Q26777534-A0806F75-B62B-4D44-BC7D-3B055D9CA499Q26823120-C1A990BC-A6FB-402C-8CAF-352D4D6655CBQ26825856-3450D1D0-4769-4BF4-8B8E-6950D03708E1Q26996022-EE570AF4-55F5-4354-B589-A0F08BCEF37BQ27023485-D0DE46D6-D244-4010-BB7C-400C1ACF5887Q28077515-D72F0B2A-8784-4A0E-A214-699C6085535AQ33572489-35B99F5B-1541-4624-A60A-DE4E01170320Q33718251-E29498CE-4B27-4BDE-8A27-CC8E36225CDEQ34129365-ABD8EEAC-C4F9-44DA-AB48-99A9BF0FAF76Q34780560-78D34CB3-9197-448A-AD7B-95AD3386F0C9Q35014658-1FD9A72B-D05C-4BFD-A9F2-0C2491E7CDFCQ35671658-EB19FFC3-7C0C-4DBF-9821-D9201A430E48Q35742424-F6EE08B4-1F5E-4DCD-A971-A450D804E6B8Q35850519-1954F14B-6CD3-4833-A3B1-481126112131Q36103386-770F3441-7811-4F23-9AA5-B251CF2CB015Q36120631-55AB70CF-DF7F-4ABE-870A-F26C9453B897Q36135237-BFC92FF7-52E1-4683-BE51-E2F711BFBF41Q36166571-F9D0901C-4E30-42C0-AE35-69E88B8FCDCCQ36316310-EA75F9C7-A866-4B64-852F-58EA925D6106Q36451342-D4BE4766-4C09-469E-8D89-4DF12CEA7F6CQ36646605-FB9E8896-7E78-40A0-A240-4B38DC241891Q37069986-33CD8257-E239-4F16-A3F7-A7DC4DBC0D1BQ37230001-44B5F3F3-0C0A-4B12-B1A8-61DBF5F2AEA2Q37389570-E4A53D3D-AE26-4697-8504-5AE50D2F9513Q37591506-55A1E8C0-D7F8-4D09-B0A8-88CE42C4C1C6Q38096493-E8E48DC7-389B-416E-94F6-1509F7F54534Q38681982-FA8D2DF3-8FBA-4187-8DB5-228D2307AA01Q41290370-F972AAA8-6AD0-451B-AFF9-CB5E25AA5E52Q44524706-28D9CB2D-1190-4FB1-AB9A-B6D64ED31C2FQ46741594-C7F95859-FC8F-47FC-A2FC-5767D32DD32AQ58883795-6445E7E1-1867-4B06-80DC-313DC3B501AC
P2860
Inflammation, immunity, and vaccine development for Helicobacter pylori.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Inflammation, immunity, and vaccine development for Helicobacter pylori.
@en
Inflammation, immunity, and vaccine development for Helicobacter pylori.
@nl
type
label
Inflammation, immunity, and vaccine development for Helicobacter pylori.
@en
Inflammation, immunity, and vaccine development for Helicobacter pylori.
@nl
prefLabel
Inflammation, immunity, and vaccine development for Helicobacter pylori.
@en
Inflammation, immunity, and vaccine development for Helicobacter pylori.
@nl
P2860
P1433
P1476
Inflammation, immunity, and vaccine development for Helicobacter pylori
@en
P2093
Anne Müller
P2860
P356
10.1111/J.1523-5378.2011.00877.X
P478
16 Suppl 1
P577
2011-09-01T00:00:00Z